According to Foghorn Therapeutics's latest financial reports the company's current revenue (TTM ) is €24.43 Million. In 2023 the company made a revenue of €30.89 Million an increase over the revenue in the year 2022 that were of €17.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.